HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

BACKGROUND: Antiretroviral pre-exposure prophylaxis (PrEP) is a novel HIV prevention strategy for which adherence is a known determinant of efficacy. Blood concentrations of PrEP medications are one objective marker of adherence. METHODS: In a placebo-controlled PrEP efficacy trial of tenofovir diso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Donnell, Deborah, Baeten, Jared M., Bumpus, Namandjé N., Brantley, Justin, Bangsberg, David R., Haberer, Jessica E., Mujugira, Andrew, Mugo, Nelly, Ndase, Patrick, Hendrix, Craig, Celum, Connie
Formato: Artigo
Idioma:Inglês
Publicado em: JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Assuntos:
Epidemiology and Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4059553/
https://ncbi.nlm.nih.gov/pubmed/24784763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados